更紧凑的生命科学资讯库。
先搜索,再按来源或主题继续收窄。
GE医疗将以23亿美元收购影像软件供应商Intelerad
With its focus on radiology and cardiology practices, as well as assisting in clinical trials, Intelerad’s outpatient footprint will serve as a complement to GE HealthC...
罗氏早期giredestrant成果获赞 | ApexOnco - 临床试验新闻与分析 - 肿瘤学研发管线
Roche touts early giredestrant success | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
罗氏公布giredestrant治疗乳腺癌的III期临床试验积极数据——临床试验竞技场
Roche reports positive Phase III data of giredestrant for breast cancer Clinical Trials Arena
罗氏凭借三期多发性硬化症试验胜利评估首款BTK抑制剂获批前景——临床试验竞技场
Roche sizes up first BTK inhibitor approval on Phase III MS victory Clinical Trials Arena
罗氏Gazyva/Gazyvaro治疗系统性红斑狼疮的III期试验达到主要终点——临床试验竞技场
Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint Clinical Trials Arena
赛默飞世尔以88亿美元收购Clario——临床试验领域动态
Thermo Fisher to buy Clario for $8.8bn Clinical Trials Arena
罗氏推进新型骨髓瘤靶点研究 | ApexOnco - 临床试验新闻与分析 - 肿瘤学研发管线
Roche pushes a novel myeloma target | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
罗氏凭借divarasib提前布局 | ApexOnco - 临床试验新闻与分析 - 肿瘤学研发管线
Roche looks earlier with divarasib | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
罗氏在5,000名患者试验后放弃其TIGIT项目 | ApexOnco - 临床试验新闻与分析 - 肿瘤学研发管线
5,000 patients later Roche scraps its TIGIT | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
把品牌目录放在视野里,但不抢主叙事
把工具、CRO、生物制药和器械公司做成滚动资源带,作为资讯流下方的辅助索引。
查看关于页